AWMM
DYN icon

Aegis Wealth Management (Maryland)’s Dyne Therapeutics DYN Stock Holding History

Aegis Wealth Management (Maryland)’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Buy
150,030
+15,000
+11% +$279K 1.57% 16
2026
Q1 		$2.45M Buy
135,030
+59,122
+78% +$1.02M 1.4% 19
2025
Q4 		$1.48M Buy
75,908
+26,000
+52% +$492K 0.84% 32
2025
Q3 		$631K Buy
49,908
+16,680
+50% +$190K 0.34% 57
2025
Q2 		$348K Hold
33,228
– – 0.21% 77
2025
Q1 		$348K Buy
+33,228
New +$475K 0.2% 81

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Aegis Wealth Management (Maryland)'s DYN Position: Q2 2026 in Review

Aegis Wealth Management (Maryland) increased its Dyne Therapeutics (DYN) stake by 11% in Q2 2026, buying an estimated $279K and bringing the position to 150,030 shares worth $3.33M. The position accounts for 1.57% of the portfolio, ranked #16.

Aegis Wealth Management (Maryland) first reported a position in DYN in Q1 2025 and has held it in 6 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Aegis Wealth Management (Maryland) held 150,030 shares of Dyne Therapeutics worth $3.33M as of Q2 2026.
  • Aegis Wealth Management (Maryland) bought 15,000 Dyne Therapeutics shares in Q2 2026, an estimated $279K.
  • Dyne Therapeutics made up 1.57% of Aegis Wealth Management (Maryland)'s portfolio in Q2 2026, its #16 holding.
  • Aegis Wealth Management (Maryland) first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Aegis Wealth Management (Maryland)'s 13F filing for Q2 2026, filed 7 Aug 2026.